Slingeland Ziekenhuis

At Slingeland Ziekenhuis in Doetinchem, clinical research in cardiovascular diseases focuses on major conditions such as atherosclerotic cardiovascular disease, atrial fibrillation, myocardial infarction, peripheral arterial disease, and heart failure. These studies are largely aimed at testing new treatments and prevention strategies that may lower the risk of serious heart and circulation events.

• Improving prevention of heart attack, stroke, and urgent revascularization in high-risk patients
• Evaluating therapies for atrial fibrillation and cardioembolic risk
• Studying approaches to better manage residual vascular risk in peripheral artery disease

Research here also includes personalized and outcome-focused care, with the goal of refining treatment choices for people living with chronic cardiovascular conditions.

In the field of hemic and lymphatic diseases, the site is involved in studies of acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma, follicular lymphoma, and marginal zone lymphoma. The research is centered on improving treatment effectiveness and finding better ways to balance disease control with tolerability.

• Testing new combinations for leukemia and high-risk myelodysplasia
• Comparing treatment options for relapsed or refractory lymphomas
• Exploring flexible treatment strategies in multiple myeloma

These trials reflect a strong interest in advancing care for blood cancers through more tailored and practical treatment approaches.

Clinical trial activity in neoplasms covers several cancer types, including breast cancer, triple negative breast cancer, metastatic colorectal cancer, colon cancer, and non-metastatic resectable pancreatic cancer. The studies are designed to assess new therapies, optimize existing cancer treatment, and improve survival outcomes.

• Evaluating adjuvant and perioperative treatment strategies in pancreatic and colon cancer
• Studying targeted and immune-based approaches in breast cancer
• Assessing treatment adjustment strategies for advanced colorectal cancer

At Slingeland Ziekenhuis, oncology research supports more personalized cancer care, especially for patients with early-stage, residual, or advanced disease.

Research in nervous system diseases is mainly focused on multiple sclerosis, with studies looking at ways to individualize long-term treatment and maintain control of disease activity. The trials aim to improve how therapy is delivered while preserving effectiveness and safety.

• Personalizing treatment schedules for multiple sclerosis
• Reducing treatment burden while maintaining disease suppression
• Supporting more flexible, real-world care strategies

This work reflects a broader effort to make neurological treatment more adaptive to patient needs.

The nutritional and metabolic diseases portfolio includes studies in obesity, type 2 diabetes mellitus, and related cardiovascular risk conditions. These trials are examining whether newer therapies can improve metabolic control and reduce long-term complications.

• Testing treatments for obesity and overweight linked to cardiovascular risk
• Evaluating diabetes therapies with potential heart-protective benefits
• Studying approaches that target both metabolic disease and vascular outcomes

The research combines metabolic care with prevention of heart and vascular disease, highlighting a strong prevention-oriented focus.

Within respiratory tract diseases, the site is involved in research on respiratory tract infection and hospitalized patients with acute respiratory illness. These trials are aimed at improving recovery, reducing mortality, and identifying better treatment options for serious infections.

• Assessing interventions for hospitalized respiratory infections
• Improving outcomes in acute community-acquired pneumonia
• Supporting better care for patients with severe respiratory illness

The studies address a clinically important area where faster recovery and better survival can make a major difference.